Arthur Sands
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
-
- Diabetes Treatment and Management
Papers in
-
- CRISPR and Genetic Engineering 7
- DNA Repair Mechanisms 5
- Oncology 18
- Cancer-related Molecular Pathways 10
- CAR-T cell therapy research 6
- Co-authors
- Brian Zambrowicz (37 shared papers)Allan Bradley (7 shared papers)Gregor Eichele (2 shared papers)Dae‐Sik Lim (2 shared papers)Paul Hasty (2 shared papers)Stephen J. Elledge (1 shared paper)Susan B. Parker (1 shared paper)Pumin Zhang (1 shared paper)
- Journals
- Blood (3 papers)Proceedings of the National Academy of Sciences (3 papers)Veterinary Pathology (3 papers)Nature (3 papers)Oncogene (3 papers)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Arthur Sands
62 papers receiving 6.4k citations
Arthur Sands's Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 2.0k
- Endocrinology, Diabetes and Metabolism 1.0k
- Molecular Biology 3.8k
- Cancer Research 623
- Aging 66
Countries citing papers authored by Arthur Sands
This map shows the geographic impact of Arthur Sands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Sands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Sands more than expected).
Fields of papers citing papers by Arthur Sands
This network shows the impact of papers produced by Arthur Sands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Sands. The network helps show where Arthur Sands may publish in the future.
Co-authors
The 25 scholars most cited alongside Arthur Sands, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | p53-Independent Expression of p21 Cip1 in Muscle and Other Terminally Differentiating Cells Hit paper breakdown → | 1995 | 925 |
| 2 | Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 Hit paper breakdown → | 1997 | 848 |
| 3 | In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. | 1993 | 415 |
| 4 | 1998 | 371 | |
| 5 | 2002 | 267 | |
| 6 | 2013 | 263 | |
| 7 | 2001 | 241 | |
| 8 | 2017 | 213 | |
| 9 | 1995 | 208 | |
| 10 | 2012 | 204 | |
| 11 | 2015 | 183 | |
| 12 | mdmx is a negative regulator of p53 activity in vivo. | 2002 | 160 |
| 13 | 2013 | 158 | |
| 14 | 2007 | 155 | |
| 15 | 2000 | 135 | |
| 16 | 2012 | 132 | |
| 17 | 2011 | 111 | |
| 18 | 2014 | 104 | |
| 19 | 2008 | 100 | |
| 20 | 2015 | 98 |
About Arthur Sands
Arthur Sands is a scholar working on Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism, Genetics and Surgery, having authored 62 papers that have together received 6.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (11 papers), Cancer-related Molecular Pathways (10 papers), CRISPR and Genetic Engineering (7 papers), CAR-T cell therapy research (6 papers), DNA Repair Mechanisms (5 papers), Neuroblastoma Research and Treatments (5 papers), Pancreatic function and diabetes (5 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Oncology (2.0k citations), Endocrinology, Diabetes and Metabolism (1.0k citations), Molecular Biology (3.8k citations), Cancer Research (623 citations) and Aging (66 citations). Arthur Sands has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Brian Zambrowicz, Allan Bradley, Gregor Eichele, Dae‐Sik Lim, Paul Hasty, Stephen J. Elledge, Susan B. Parker, Pumin Zhang, Alan Rawls and J. Wade Harper. Their work appears in journals such as Blood, Proceedings of the National Academy of Sciences, Veterinary Pathology, Nature and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.